Abstract: The present disclosure relates to a composition comprising naringin, and daidzein, and uses thereof. The disclosure also provides for a method of use of the said composition for neuro-protective effect.
Claims:1. A composition for neuro-protection, said composition comprising:
a) naringin; and
b) daidzein;
wherein, naringin to daidzein w/w ratio in said composition is in the range of 0.25:1-4:1.
2. A method of preparing a composition as claimed in claim 1.
3. A formulation for neuro-protection, said formulation comprising:
a) naringin;
b) daidzein; and
c) at least one carrier, diluent, and excipient,
wherein naringin to daidzein w/w ratio in said formulation is in the range of 0.25:1-4:1.
4. A method of preparing a formulation as claimed in claim 3.
5. A method for neuro-protection, said method comprising the steps:
a. obtaining a composition comprising:
i. naringin; and
ii. daidzein,
wherein naringin to daidzein w/w ratio in said composition is in the range of 0.25:1-4:1; and
b. contacting said composition with site of neuronal presence,
8. wherein said method provides neuro-protection.
9. 6. A method for neuro-protection, said method comprising the steps:
a. obtaining a formulation comprising:
i. naringin;
ii. daidzein; and
iii. at least one carrier, diluent, and excipient
wherein naringin to daidzein w/w ratio in said formulation is in the range of 0.25:1-4:1; and
b. contacting said formulation with site of neuronal presence,
wherein said method provides neuro-protection.
, Description:N/A
| # | Name | Date |
|---|---|---|
| 1 | 5656-CHE-2015-FER.pdf | 2021-10-17 |
| 1 | Form 5 [20-10-2015(online)].pdf | 2015-10-20 |
| 2 | 5656-CHE-2015-Response to office action [23-09-2021(online)].pdf | 2021-09-23 |
| 2 | Form 3 [20-10-2015(online)].pdf | 2015-10-20 |
| 3 | 5656-CHE-2015-FORM 18 [05-09-2019(online)].pdf | 2019-09-05 |
| 3 | Drawing [20-10-2015(online)].pdf | 2015-10-20 |
| 4 | 5656-CHE-2015-Correspondence-F1-PA-281215.pdf | 2016-06-14 |
| 4 | Description(Complete) [20-10-2015(online)].pdf | 2015-10-20 |
| 5 | 5656-CHE-2015-Power of Attorney-281215.pdf | 2016-06-14 |
| 5 | 5656-CHE-2015-Form 1-281215.pdf | 2016-06-14 |
| 6 | 5656-CHE-2015-Form 1-281215.pdf | 2016-06-14 |
| 6 | 5656-CHE-2015-Power of Attorney-281215.pdf | 2016-06-14 |
| 7 | 5656-CHE-2015-Correspondence-F1-PA-281215.pdf | 2016-06-14 |
| 7 | Description(Complete) [20-10-2015(online)].pdf | 2015-10-20 |
| 8 | 5656-CHE-2015-FORM 18 [05-09-2019(online)].pdf | 2019-09-05 |
| 8 | Drawing [20-10-2015(online)].pdf | 2015-10-20 |
| 9 | 5656-CHE-2015-Response to office action [23-09-2021(online)].pdf | 2021-09-23 |
| 9 | Form 3 [20-10-2015(online)].pdf | 2015-10-20 |
| 10 | Form 5 [20-10-2015(online)].pdf | 2015-10-20 |
| 10 | 5656-CHE-2015-FER.pdf | 2021-10-17 |
| 1 | 5656searchE_25-03-2021.pdf |